The Valley Desk

NCT01665391 · Interventional trial

A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)

Overall registry status Completed

Phase 2

Conditions Primary Focal Segmental Glomerulosclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov